RedCare Pharmacy NV expects revenue from the German prescription business to reach 730 million to 760 million euros in 2026, an increase of 45% to 51% over the previous year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.